全文获取类型
收费全文 | 4367篇 |
免费 | 194篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 73篇 |
妇产科学 | 50篇 |
基础医学 | 653篇 |
口腔科学 | 67篇 |
临床医学 | 272篇 |
内科学 | 1118篇 |
皮肤病学 | 69篇 |
神经病学 | 228篇 |
特种医学 | 198篇 |
外科学 | 967篇 |
综合类 | 24篇 |
预防医学 | 79篇 |
眼科学 | 51篇 |
药学 | 248篇 |
中国医学 | 2篇 |
肿瘤学 | 463篇 |
出版年
2023年 | 17篇 |
2022年 | 45篇 |
2021年 | 63篇 |
2020年 | 39篇 |
2019年 | 50篇 |
2018年 | 73篇 |
2017年 | 59篇 |
2016年 | 93篇 |
2015年 | 91篇 |
2014年 | 139篇 |
2013年 | 166篇 |
2012年 | 254篇 |
2011年 | 268篇 |
2010年 | 156篇 |
2009年 | 162篇 |
2008年 | 246篇 |
2007年 | 288篇 |
2006年 | 312篇 |
2005年 | 350篇 |
2004年 | 321篇 |
2003年 | 339篇 |
2002年 | 330篇 |
2001年 | 39篇 |
2000年 | 40篇 |
1999年 | 57篇 |
1998年 | 63篇 |
1997年 | 68篇 |
1996年 | 42篇 |
1995年 | 50篇 |
1994年 | 46篇 |
1993年 | 50篇 |
1992年 | 25篇 |
1991年 | 31篇 |
1990年 | 20篇 |
1989年 | 27篇 |
1988年 | 10篇 |
1987年 | 17篇 |
1986年 | 14篇 |
1985年 | 16篇 |
1984年 | 19篇 |
1983年 | 13篇 |
1982年 | 19篇 |
1981年 | 17篇 |
1980年 | 14篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1974年 | 5篇 |
排序方式: 共有4595条查询结果,搜索用时 31 毫秒
91.
Assessment of Hepatic Functional Reserve in Cirrhotic Patients by Computed Tomography of the Caudate Lobe 总被引:1,自引:0,他引:1
Watanabe S Kimura Y Nishioka M Ohkawa M Kozeki M Yano M Hashimoto N 《Digestive diseases and sciences》1999,44(12):2554-2563
In order to investigate whether the size of thecaudate lobe of the cirrhotic liver is related to thehepatic functional reserve, the morphometric analysis ofthe caudate lobe was preformed retrospectively using computed tomography in 106 consecutivepatients of whom 67 had compensated (group 1), and 39uncompensated (group 2) liver cirrhosis. In 51 patients,hepatic measurements were repeated in follow-up. Age- and gender-matched controls were studied.The size of the caudate lobe and the ratio of thecaudate to right lobe were correlated with liverfunction. The caudate lobe was larger in the studypatients than in the controls, and larger in group 1than in group 2 (P < 0.01). The caudate to right loberatios were also greater in the study patientsespecially in group 1 (P < 0.01). In follow-up, the regression coefficient for the caudate to rightlobe ratio was positive in group 1 and negative in group2 (P < 0.05). Even though the caudate lobe ofpatients with uncompensated liver cirrhosis was larger than that of the controls, patients withcompensated liver cirrhosis had a larger caudate lobeand higher caudate to right lobe ratio compared to thepatients with uncompensated liver cirrhosis. The caudate lobe may have played an importantrole in maintaining proper liver function in thesepatients. 相似文献
92.
93.
Yasushi Okuaki Hiroshi Miyazaki Mikio Zeniya Tomohisa Ishikawa Yasuhiko Ohkawa Shinichi Tsuno Masami Sakaguchi Masaki Hara Hiroki Takahashi Gotaro Toda 《Liver international》1996,16(3):188-194
Abstract: In the present study, we investigated the role of the spleen in experimental hepatic ischemia/reperfusion in the rat. After a 90-min period of ischemia in the left and middle hepatic lobes, the ischemia was released and the liver was reperfused for up to 24 h. Plasma alanine aminotransferase reached a peak 3 h after the onset of reperfusion, and gradually decreased thereafter. A histological examination revealed evidence of hepatocellular necrosis and degeneration, especially 24 h after the onset of reperfusion. In addition, there was a noticeable accumulation of polymorphonuclear cells in the liver following ischemia/reperfusion. A splenectomy performed just prior to ischemia/reperfusion reduced both biochemical and histological hepatocellular injury. The number of polymorphonuclear cells in the liver following ischemia/reperfusion was significantly reduced in rats subjected to splenectomy, suggesting that the increase in polymorphonuclear cells may contribute to liver injury. The number of mononuclear cells also increased in the marginal zones of the spleen following ischemia/reperfusion, and appeared to be derived from the splenic monocyte/macrophage population, based on immunohistochemical studies. The spleen plays an important role in the pathogenesis of hepatic ischemia/reperfusion injury and the splenic monocyte/macrophage population contributes to liver damage. 相似文献
94.
Nobuyoshi Kawakita Shuichi Seki Hiroki Sakaguchi Atsushi Yanai Kazuki Nakatani Takao Yamada Takuya Kitada Yasuhiko Sakai Tetsuo Kuroki Kenzo Kobayashi Takeyuki Monna 《Liver international》1994,14(6):295-301
ABSTRACT: The retinoblastoma gene product is a nuclear phosphoprotein that undergoes cell cycle-dependent changes in its phosphorylation status. To analyze the expression of retinoblastoma gene product in the process of liver regeneration and the initiation of hepatocellular carcinoma, we studied immunohistochemically the expression of retinoblastoma gene product and DNA polymerase alpha (DPA) in 33 patients with various liver diseases. Only a few hepatocytes positive for retinoblastoma gene product were found in undamaged, nonregenerating liver tissues, whereas many hepatocytes positive for retinoblastoma gene product were detected in specimens of regenerating liver obtained from patients with acute or chronic liver diseases. Similarities were found between distribution patterns of hepatocytes positive for retinoblastoma gene product and those of hepatocytes positive for DPA, and a highly significant positive correlation was found between the number of hepatocyte nuclei stained for retinoblastoma gene product per 1000 nuclei examined (R-LI) and the number of hepatocyte nuclei stained for DPA per 1000 nuclei examined (D-LI) in tissues obtained from patients with nonmalignant liver disease. Hepatocellular carcinoma cells positive for DPA were detected in the 14 hepatocellular carcinoma specimens tested. In ten of these specimens, hepatocellular carcinoma cells positive for retinoblastoma gene product were found but not in the other four. For all hepatocellular carcinoma specimens, R-LI was proportional to D-LI. Thus in both nonmalignant and malignant liver, retinoblastoma gene product increased in proportion to proliferation of hepatocytes or hepatocellular carcinoma cells. 相似文献
95.
Nakamura K Funabashi N Miyauchi H Aminaka M Uehara M Ueda M Murayama T Hori Y Nakayama T Daimon M Kuroda N Kobayashi Y Komuro I 《International journal of cardiology》2008,127(3):437-441
We report the case of a 38-year-old Asian man with a pericardial hemangioma on the left main coronary artery. The patient presented initially at our hospital after cardiopulmonary resuscitation following an episode of ventricular fibrillation (VF). Because of spontaneous coved-type ST segment elevation on the higher intercostal space V1 to V2 in a 12-lead electrocardiogram, documented VF in the absence of structural heart disease, and a family history of sudden death, he was diagnosed with Brugada syndrome. Transesophageal echocardiography showed a smooth-surfaced mass with well-demarcated borders, directly above the left main coronary artery. Computed tomography confirmed the presence of the mass, which showed no enhancement at early phase, but did demonstrate homogenous enhancement at delay phase by contrast material. There were no findings from either the nuclear medicine or the tumor marker investigations which indicated that the mass located just above the main coronary arteries was malignant. Therefore, taken together, these findings suggested that the tumor might be a pericardial hemangioma. The relationship between the location of the hemangioma just above the left main coronary artery and the occurrence of VF was not clear, i.e. whether the presence of the hemangioma caused the stimulation of the left main coronary artery and as a result, led to the spasm of the left main coronary artery and the occurrence of VF. Furthermore, as the tumor did not extend into any of the adjacent structures, such as the coronary arteries or the right ventricular outflow tract, surgical resection was not performed; instead, the patient received a dual chamber implantable cardioverter-defibrillator. 相似文献
96.
Takahiro Shoji Takehiko Tarui Takashi Igarashi Yuki Mochida Hiroyuki Morinaga Yasuhiko Miyakuni Yoshitaka Inoue Yasuhiko Kaita Hiroshi Miyauchi Yoshihiro Yamaguchi 《The Journal of emergency medicine》2018,54(4):410-418
Background
Bleeding from hemorrhagic shock can be immediately controlled by blocking the proximal part of the hemorrhagic point using either resuscitative thoracotomy for aortic cross-clamping or insertion of a large-caliber (10–14Fr) resuscitative endovascular balloon occlusion of the aorta (REBOA) device via the femoral artery. However, such methods are very invasive and have various complications. With recent progress in endovascular treatment, a low-profile REBOA device (7Fr) has been developed.Objective
The objective of this study was to report our experience of this low-profile REBOA device and to evaluate the usefulness of emergency physician?operated REBOA in life-threatening hemorrhagic shock.Methods
Ten patients with refractory hemorrhagic shock underwent REBOA using this device via the femoral artery. All REBOA procedures were performed by emergency physicians. The success rate of the insertion, vital signs, and REBOA-related complications were evaluated.Results
Median age was 54 years (interquartile range 33–78 years). The causes of hemorrhagic shock were trauma (n = 4; 1 blunt and 3 penetrating), ruptured abdominal aortic aneurysm (n = 3), and obstetric hemorrhage (n = 3). Two patients had cardiopulmonary arrest upon arrival. REBOA procedure was successful in all patients, and all became hemodynamically stable to undergo definitive interventions after REBOA. There were no REBOA-related complications. The mortality rate within 24 h and 30 days was 40%.Conclusions
This REBOA device was useful for emergency physicians in life-threatening hemorrhagic shock because of its ease in handling and low invasiveness. 相似文献97.
Yuichiro Yamada Yasuo Terauchi Hirotaka Watada Yasuhiko Nakatsuka Kazuhito Shiosakai Takuo Washio Takashi Taguchi 《Advances in therapy》2018,35(3):367-381
Introduction
G protein-coupled receptor 119 (GPR119) is a promising target for the treatment of type 2 diabetes mellitus (T2DM), as both insulin and glucagon-like peptide-1 secretion can be promoted with a single drug. We compared the efficacy and safety of the GPR119 agonist DS-8500a with placebo and sitagliptin 50 mg in Japanese patients with T2DM.Methods
This randomized, double-blind, parallel-group comparison study was conducted in Japan (trial registration NCT02628392, JapicCTI-153068). Eligible patients aged ≥ 20 years with T2DM and hemoglobin A1c (HbA1c) ≥ 7.0% and < 10.0% were randomized to receive placebo, DS-8500a (25, 50, or 75 mg), or sitagliptin 50 mg once daily for 12 weeks. The primary efficacy endpoint was change in HbA1c from baseline to week 12. Secondary endpoints included change in fasting plasma glucose (FPG), glucose AUC0–3h during a meal tolerance test, 2-hour postprandial glucose (2hr-PPG), and changes in lipid parameters (total, low-density lipoprotein (LDL-) and high-density lipoprotein (HDL-) cholesterol, and triglycerides) at week 12. Safety endpoints included adverse events, hypoglycemia, and clinical/laboratory variables.Results
DS-8500a demonstrated dose-dependent HbA1c lowering compared with placebo at week 12: change from baseline ? 0.23% (p = 0.0173), ? 0.37% (p = 0.0001), and ? 0.44% (p < 0.0001) in the 25-mg, 50-mg, and 75-mg groups, respectively. At 50- and 75-mg doses, DS-8500a significantly lowered FPG, glucose AUC0–3h, and 2hr-PPG compared with placebo. The glucose-lowering effect was maintained up to 12 weeks. DS-8500a did not lower any of the above parameters to a greater extent than sitagliptin. Compared with placebo and sitagliptin, DS-8500a 50 and 75 mg significantly reduced total cholesterol, LDL-cholesterol, and triglycerides, and significantly increased HDL-cholesterol. All DS-8500a doses were well tolerated. Two cases of clinically relevant drug-related hypoglycemia occurred in the DS-8500a 50-mg group.Conclusion
DS-8500a was well tolerated and demonstrated significant glucose-lowering effects and favorable changes in lipid profiles up to 12 weeks in Japanese patients with T2DM.Funding
Daiichi Sankyo Co. Ltd.98.
Allahwala Usaid K. Nour Daniel Alsanjari Osama Bhatia Kunwardeep Nagaraja Vinayak Khatri Jaikirshan J. Cockburn James Hildick-Smith David Sakata Yasuhiko Ward Michael Weaver James C. Bhindi Ravinay 《Journal of thrombosis and thrombolysis》2021,51(4):1005-1016
Journal of Thrombosis and Thrombolysis - Acute coronary collateralisation of an infarct-related arterial (IRA) territory may be identified during angiography for ST elevation myocardial infarction... 相似文献
99.
100.
p53 point mutations in primary human gastric carcinomas 总被引:12,自引:0,他引:12
Hiroshi Yokozaki Hiroki Kuniyasu Yasuhiko Kitadai Kenji Nishimura Hiroko Todo Ayşe Ayhan Wataru Yasui Hisao Ito Eiichi Tahara 《Journal of cancer research and clinical oncology》1992,119(2):67-70
Summary p53 point mutations in primary gastric carcinomas were analyzed by performing cDNA deoxynucleotide sequencing of the gene. Out of 16,9 (56.3%) primary gastric carcinoma cases, including early cancer, showed one or more p53 point mutations in their open-reading frame, and 4 out of 9 cases had a p53 point mutation within highly conserved domains. The characteristics of the p53 mutation spectrum observed in primary tumors were (a) frequent mutation at an A:T pair (50%, 7 out of 14 mutations), (b) high transversion incidence (29%, 4 out of 14 mutations), (c) no transition at CpG, and (d) no G:C to T:A transversion. Our results suggest that p53 mutation is a common event in gastric carcinoma occurring from the early stage of progression with its specific mutation spectrum.Abbreviation PCR-SSCP
polymerase chain reaction single-strand conformation polymorphism 相似文献